We are live on
!
Find out more
GP
GSK plc Portfolio holdings
AUM
$599M
This Fund
S&P 500
This Quarter
Est. Return
+55.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$799M
AUM Growth
–
Cap. Flow
+$686M
Cap. Flow
% of AUM
85.87%
Top 10 Holdings %
Top 10 Hldgs %
97.88%
Holding
15
New
15
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CRISPR Therapeutics
CRSP
|
+$193M |
| 2 |
Wave Life Sciences
WVE
|
+$185M |
| 3 |
BioNTech
BNTX
|
+$89.6M |
| 4 |
Vir Biotechnology
VIR
|
+$50.9M |
| 5 |
IDEAYA Biosciences
IDYA
|
+$42.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.14B
| $310M | 38.82% |
+18,245,691
| New | +$185M |
|
|
2
CRISPR Therapeutics
CRSP
$4.99B
| $169M | 21.14% |
+3,220,627
| New | +$193M |
|
|
3
BioNTech
BNTX
$22.8B
| $84.7M | 10.6% |
+889,824
| New | +$89.6M |
|
|
4
Vir Biotechnology
VIR
$1.64B
| $51.6M | 6.45% |
+8,550,954
| New | +$50.9M |
|
5
Lyell Immunopharma
LYEL
$334M
| $46.6M | 5.83% |
+1,512,659
| New | +$33.9M |
|
|
6
IDEAYA Biosciences
IDYA
$3.48B
| $46.1M | 5.77% |
+1,333,333
| New | +$42.5M |
|
7
Cytokinetics
CYTK
$11.2B
| $21.6M | 2.71% |
+340,434
| New | +$21.2M |
|
8
Spero Therapeutics
SPRO
$126M
| $21.4M | 2.68% |
+9,190,606
| New | +$21.3M |
|
9
Fulcrum Therapeutics
FULC
$236M
| $20.2M | 2.53% |
+1,785,714
| New | +$18.2M |
|
|
BCYC
10
Bicycle Therapeutics
BCYC
$304M
| $10.8M | 1.36% |
+1,529,561
| New | +$11.3M |
|
11
CVRx
CVRX
$144M
| $7.15M | 0.9% |
+1,007,583
| New | +$9.2M |
|
12
Nkarta
NKTX
$200M
| $5.83M | 0.73% |
+3,150,732
| New | +$6.3M |
|
13
Regenxbio
RGNX
$659M
| $3.91M | 0.49% |
+271,456
| New | +$3.38M |
|
14
Senseonics Holdings Inc
SENS
$276M
| $59.9K | 0.01% |
+10,856
| New | +$75.5K |
|
15
Harvard Bioscience
HBIO
$27.6M
| $7.46K | ﹤0.01% |
+1,115
| New | +$6.61K |
|
Similar funds
BHPW
SCM
CCP
FSG
CNBTD
CTA
ECM
OCAM